Wedelolactone, isolated from Wedelia chinensis, has been found to modulate the androgen receptor (AR) activation of transcription from prostate-specific antigen promoter in prostate cancer (PCa) cells [130]. The gene discussed is AR; the disease is prostate carcinoma.